A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

Epilepsy Clinical Trial

Official title: A Multi-center,Open-label Real-world Study to Evaluate the Efficacy and Pharmaco-economics of Lacosamide as First Add-on Therapy for Adults and Children With Focal Onset Seizures

Status Not yet recruiting

Clinical Trial Summary

The purpose of this trial is to evaluate the efficacy, safety, and pharmaco-economics of Lacosamide Tablet as first add-on therapy for uncontrolled focal onset epilepsy ,invetigating effects of lacosamide Tablet on cognitive function of children and anxiety and depression of adults with focal onset seizures In real-world clinical setting

Clinical Trial Description

In many real world, lacosamide as the first add-on therapy can significantly improve the seizure freedom rate. Moreover, many pharmacoeconomic studies in Sweden and the United States have confirmed that lacosamide is a more cost-effective option.This is a real-world study to evaluate the efficacy, safety and cost-effectiveness of Generic lacoxamide tablets in the treatment of patients with focal epilepsy. During the trial, patients with focal epilepsy were treated with lacosamide for the first time after the failure of the original antiepileptic drug. At the same time, the cost-effectiveness of Generic lacosamide was evaluated from the perspective of economics, in order to provide the basis for the clinical choice for Chinese epilepsy patients. ;

Related Conditions & MeSH terms

• Epilepsy
• Focal-Onset Seizure
• Seizures

• NCT number: NCT04737837
• Study type: Observational [Patient Registry]
• Source: Jiangxi Qingfeng Pharmaceutical Co. Ltd.
• Contact: Ruipeng Zhang, MA
• Phone: 13654951067
• Email: zhangruipeng@qfyy.com.cn
• Status: Not yet recruiting
• Start date: January 31, 2021
• Completion date: February 28, 2022